Taysha Gene Therapies Inc (TSHA) — Strategic Asset Allocation Index
Taysha Gene Therapies Inc (TSHA) has a Strategic Asset Allocation Index of 2729.8% as of December 2022. Strategic assets (PP&E of $25.91 Million plus long-term investments of $-) total $25.91 Million, measured against net assets of $949.00K. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See TSHA equity to assets ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Taysha Gene Therapies Inc Strategic Asset Allocation Index (2020–2021)
This chart shows how Taysha Gene Therapies Inc's Strategic Asset Allocation Index has evolved across 2 annual periods from 2020 to 2021. As of December 2022, the index stands at 2729.8%, representing strategic assets of $25.91 Million against net assets of $949.00K USD. For live market cap and overall valuation, see TSHA company net worth.
Annual Strategic Asset Allocation Index for Taysha Gene Therapies Inc (2020–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Taysha Gene Therapies Inc from 2020 to 2021, covering 2 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Taysha Gene Therapies Inc net assets for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 53.1% | $50.61 Million | $50.61 Million | $- | $95.38 Million | ▲ +52.9 pp |
| 2020 | 0.1% | $287.00K | $287.00K | $- | $251.30 Million | — |